141 related articles for article (PubMed ID: 36287042)
1. Comparison of single photon emission computed tomography-computed tomography, computed tomography and magnetic resonance imaging of medication-related osteonecrosis of jaw by new calculated parameters.
Minami Y; Ogura I
Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):126-132. PubMed ID: 36287042
[TBL] [Abstract][Full Text] [Related]
2. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
Ogawa R; Ogura I
Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
[TBL] [Abstract][Full Text] [Related]
3. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
4. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
5. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
Tezuka Y; Ogura I
Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
[TBL] [Abstract][Full Text] [Related]
6. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m hydroxymethylene diphosphonate SPECT/CT for the evaluation of osteonecrosis of the jaw: preliminary study on diagnostic ability of maximum standardised uptake value.
Ogura I; Sasaki Y; Sue M; Oda T; Kameta A; Hayama K
Clin Radiol; 2020 Jan; 75(1):46-50. PubMed ID: 31699430
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
[TBL] [Abstract][Full Text] [Related]
10. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
Toshima H; Ogura I
Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
Assaf AT; Zrnc TA; Remus CC; Adam G; Zustin J; Heiland M; Friedrich RE; Derlin T
J Craniomaxillofac Surg; 2015 Oct; 43(8):1461-9. PubMed ID: 26232916
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.
Miyashita H; Kameyama K; Morita M; Nakagawa T; Nakahara T
Dentomaxillofac Radiol; 2019 Dec; 48(8):20190208. PubMed ID: 31287720
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of mandibular bone marrow using computed tomography texture analysis for detect stage 0 medication-related osteonecrosis of the jaw.
Ito K; Muraoka H; Hirahara N; Sawada E; Hirohata S; Otsuka K; Okada S; Kaneda T
Eur J Radiol; 2021 Dec; 145():110030. PubMed ID: 34798536
[TBL] [Abstract][Full Text] [Related]
15. Maximum standardized uptake value of normal structures in the head and neck with bone SPECT/CT.
Tezuka Y; Ogura I
J Med Imaging Radiat Oncol; 2022 Oct; 66(7):936-939. PubMed ID: 34989162
[TBL] [Abstract][Full Text] [Related]
16. Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
Kobayashi Y; Okui T; Tsujimoto M; Ikeda H; Satoh K; Kanamori D; Fujii N; Toyama H; Matsuo K
Ann Nucl Med; 2021 Jul; 35(7):853-860. PubMed ID: 33997910
[TBL] [Abstract][Full Text] [Related]
17. Quantification evaluation of
Huang K; Feng Y; Liu D; Liang W; Li L
Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
[TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw.
Miyashita H; Shiba H; Kawana H; Nakahara T
Int J Oral Maxillofac Surg; 2015 Sep; 44(9):1106-9. PubMed ID: 26008732
[TBL] [Abstract][Full Text] [Related]
20. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
